Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students

被引:9
|
作者
Popp, Jonah [1 ]
Nyman, John A. [1 ]
Luo, Xianghua [2 ,3 ]
Bengtson, Jill [4 ]
Lust, Katherine [5 ]
An, Lawrence [6 ]
Ahluwalia, Jasjit S. [7 ]
Thomas, Janet L. [4 ]
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, 420 Delaware St SE,MMC 729, Minneapolis, MN 55414 USA
[2] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[4] Univ Minnesota, Dept Med, Div Gen Internal Med, Box 736 UMHC, Minneapolis, MN 55455 USA
[5] Univ Minnesota, Boynton Hlth Serv, Minneapolis, MN USA
[6] Univ Michigan, Ctr Hlth Commun Res, Ann Arbor, MI 48109 USA
[7] Brown Univ, Providence, RI 02912 USA
来源
EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2018年 / 19卷 / 09期
关键词
Economic evaluation; Cost utility; Smoking cessation; Financial incentives; College smoking; Decision-analytic model; CIGARETTE-SMOKING; DECISION-MAKING; FOLLOW-UP; HEALTH; ABSTINENCE; BENEFITS; INTERVENTION; SIMULATION; STRATEGIES; SMOKERS;
D O I
10.1007/s10198-018-0977-z
中图分类号
F [经济];
学科分类号
02 ;
摘要
ObjectivesWe conducted a cost-effectiveness analysis and model-based cost-utility and cost-benefit analysis of increased dosage (3 vs. 1 consecutive contests) and enhanced content (supplemental smoking-cessation counseling) of the Quit-and-Win contest using data from a randomized control trial enrolling college students in the US.MethodsFor the cost-utility and cost-benefit analyses, we used a microsimulation model of the life course of current and former smokers to translate the distribution of the duration of continuous abstinence among each treatment arm's participants observed at the end of the trial (N=1217) into expected quality-adjusted life-years (QALYs) and costs and an incremental net monetary benefit (INMB). Missing observations in the trial were classified as smoking. For our reference case, we took a societal perspective and used a 3% discount rate for costs and benefits. A probabilistic sensitivity analysis (PSA) was performed to account for model and trial-estimated parameter uncertainty. We also conducted a cost-effectiveness analysis (cost per additional intermediate cessation) using direct costs of the intervention and two trial-based estimates of intermediate cessation: (a) biochemically verified (BV) 6-month continuous abstinence and (b) BV 30-day point prevalence abstinence at 6months.ResultsMultiple contests resulted in a significantly higher BV 6-month continuous abstinence rate (RD0.04), at a cost of $1275 per additional quit, and increased the duration of continuous abstinence among quitters. In the long run, multiple contests lead to an average gain of 0.03 QALYs and were cost saving. Incorporating parameter uncertainty into the analyses, the expected INMB was greater than $1000 for any realistic willingness to pay (WTP) for a QALY.ConclusionsAssuming missing values were smoking, multiple contests appear to dominate a single contest from a societal perspective. Funding agencies seeking to promote population health by funding a Quit-and-Win contest in a university setting should strongly consider offering multiple consecutive contests. Further research is needed to evaluate multiple contests compared to no contest.
引用
收藏
页码:1319 / 1333
页数:15
相关论文
共 50 条
  • [21] Cost-Effectiveness of a Smoking Cessation Program Implemented at the Time of Surgery for Lung Cancer
    Slatore, Christopher G.
    Au, David H.
    Hollingworth, William
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 499 - 504
  • [22] The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression
    Barnett, Paul G.
    Wong, Wynnie
    Hall, Sharon
    [J]. ADDICTION, 2008, 103 (05) : 834 - 840
  • [23] A cost-effectiveness analysis of a community pharmacist based smoking cessation program in Thailand
    Thavorn, K.
    Chaiyakunapruk, N.
    Nimpitakpong, P.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A472 - A472
  • [24] ASSESSING THE POTENTIAL COST-EFFECTIVENESS OF A SMOKING CESSATION PROGRAM PRIOR TO ELECTIVE SURGERY
    Kling, C. E.
    Varghese, T., Jr.
    Garrison, L.
    Veenstra, D. L.
    Flum, D.
    Alfonso-Cristancho, R.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A38 - A38
  • [25] A community-wide smoking cessation program: Quit and win 1998 in Olmsted County
    Croghan, IT
    O'Hara, MR
    Schroeder, DR
    Patten, CA
    Croghan, GA
    Hays, JT
    Dale, LC
    Bowen, D
    Kottke, T
    Hurt, RD
    [J]. PREVENTIVE MEDICINE, 2001, 33 (04) : 229 - 238
  • [26] Cost-effectiveness of methods to quit smoking in Finnish health care
    Jormanainen, VJ
    Hahl, J
    [J]. VALUE IN HEALTH, 2002, 5 (06) : 490 - 490
  • [27] Cost-effectiveness of universally funding smoking cessation pharmacotherapy
    Altman, Daniel
    Clement, Fiona M.
    Barnieh, Lianne
    Manns, Braden
    Penz, Erika
    [J]. CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2019, 3 (02) : 67 - 75
  • [28] COST-EFFECTIVENESS ANALYSIS OF SMOKING CESSATION INTERVENTIONS IN MALAYSIA
    Neoh, C. F.
    Ibrahim, N. H.
    Ismail, H.
    Hong, Y. H.
    [J]. VALUE IN HEALTH, 2018, 21 : S234 - S235
  • [29] The cost-effectiveness of the nicotine transdermal patch for smoking cessation
    Wasley, MA
    McNagny, SE
    Phillips, VL
    Ahluwalia, JS
    [J]. PREVENTIVE MEDICINE, 1997, 26 (02) : 264 - 270
  • [30] THE COST-EFFECTIVENESS ANALYSIS OF VARENICLINE FOR SMOKING CESSATION IN POLAND
    Walczak, J.
    Nogas, G.
    Dybek-Karpiuk, A.
    Augustynska, J.
    Stelmachowski, J.
    Garbacka, M.
    Obrzut, G.
    Pawlik, D.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A303 - A303